Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures

2007 ◽  
Vol 52 (13) ◽  
pp. 3817-3836 ◽  
Author(s):  
Panayiotis Mavroidis ◽  
Brigida Costa Ferreira ◽  
Chengyu Shi ◽  
Bengt K Lind ◽  
Nikos Papanikolaou
2017 ◽  
Vol 3 (2) ◽  
pp. 635-638 ◽  
Author(s):  
Henning Salz ◽  
Simon Howitz ◽  
Tim Brachwitz ◽  
Tilo Wiezorek

AbstractThe biplanar diode arrays Delta4PT and Delta4+ has been used in our hospital since the introduction of the TomoTherapy in 2013 to ensure a good agreement between the calculated and the measured dose distributions in patient-related QA with helical TomoTherapy. The aim of this presentation is to evaluate the quality of the measurement procedure with the Delta4 phantoms Delta4PT and (since January 2016) Delta4+. This includes the influence of a cross calibration with a treatment plan with low modulation.Two analyses were performed: (i) All treatment plans in a period of three months (n=86) were not only calculated and measured with Delta4PT or Delta4+ but also with an ionization chamber (Exradin A1SL) in the homogeneous “cheese phantom”. (ii) All data measured from January 2016 to April 2017 (Delta4+, n=132) were analyzed regarding median dose deviation, Gamma analysis and others.The comparison with chamber measurements shows that all measurements with Delta4 and almost all with the ionization chambers (79 of 86) yield a deviation of measured vs. planned dose in the PTV of less than 2.5%, but with a lower variation of the Delta4 measurements. However, a strong correlation between both was not observed.The separate analysis of the measurements with the newer Delta4+ (since January 2016) shows a mean dose deviation in the PTVs of only 0.14% with a standard deviation (S.D.) of 0.69%. Before every measurement a cross calibration has been performed. Without this cross calibration, the deviation would be 0.96% with an increased standard deviation of 0.93%.It is concluded that the Delta4 systems are well suited for patient-related QA for helical TomoTherapy treatment plans. The comparison with chamber measurements shows a plausible accordance between both systems whereas the variation of single measurements is quite different.With the help of a daily cross calibration the variability of the Delta4 results is further decreased and the results show higher accuracy and reliability. According to our experience, a daily cross calibration is mandatory for a reliable patient-related QA.


2020 ◽  
Vol 15 (1) ◽  
Author(s):  
HaiYang Wang ◽  
JunQi Liu ◽  
YiFei Pi ◽  
Qi Liu ◽  
Yang Mi ◽  
...  

Abstract Objective To assess the effects of various treatment planning parameters to identify the optimal gap distance for precise two-segment total body irradiation (TBI) using helical tomotherapy (HT) with fixed jaw mode. Methods and materials Data of a treatment plan for 8 acute leukemia patients (height range: 109–130 cm) were analyzed. All patients underwent total-body computed tomography (CT) with 5-mm slice thickness. A lead wire, placed at 10 cm above the patella, was used to mark the boundary between the two segments. Target volumes and organs at risk were delineated using a Varian Eclipse 10.0 physician’s workstation. Different distances between the lead wire and the boundary of the two targets were used. CT images were transferred to the HT workstation to design the treatment plans, by adjusting parameters, including the field width (FW; 2.5 cm, and 5 cm), pitch (0.287 and 0.430), modulation factor (1.8). The plans were superimposed to analyze the dose distributions in the overlap region when varying target gap distances, FWs, pitches to determine the optimal combinations. Results The pitch did not affect the dose distribution in the overlap region. The dose distribution in the overlap region was mostly homogeneous when the target gap distance was equal to the FW. Increased FW diminished the effect of the target gap distance on the heterogeneous index of the overlap region. Conclusions In two-segment TBI treatments by HT with Helix mode, a gap distance equal to the FW may achieve optimal dose distribution in the overlap region.


2017 ◽  
Vol 44 (6) ◽  
pp. 2544-2555 ◽  
Author(s):  
Emil Schüler ◽  
Kjell Eriksson ◽  
Elin Hynning ◽  
Steven L. Hancock ◽  
Susan M. Hiniker ◽  
...  

2017 ◽  
Vol 72 ◽  
pp. S102 ◽  
Author(s):  
W. Verbakel ◽  
N. Raaijmakers ◽  
L. Bos ◽  
M. Essers ◽  
C. Terhaard ◽  
...  

2014 ◽  
Vol 17 (7) ◽  
pp. A589
Author(s):  
P. Sciattella ◽  
A. Marcellusi ◽  
F.S. Mennini

Sign in / Sign up

Export Citation Format

Share Document